NewSquare Capital’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

NewSquare Capital’s Portfolio INFI Stock Details INFI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-69,548	Closed	-$81K	–	397
2020 Q3	$81K	Hold	69,548	–	–	0.01%	150
2020 Q2	$63K	Hold	69,548	–	–	0.01%	163
2020 Q1	$58K	Hold	69,548	–	–	0.01%	168
2019 Q4	$67K	Hold	69,548	–	–	0.01%	155
2019 Q3	$72K	Hold	69,548	–	–	0.01%	131
2019 Q2	$125K	Hold	69,548	–	–	0.02%	132
2019 Q1	$131K	Buy	69,548 +34,548	+99%	+$50.5K	0.03%	127
2018 Q4	$41K	Hold	35,000	–	–	0.01%	163
2018 Q3	$95K	Buy	+35,000	New	+$72.4K	0.02%	135

Other funds holding INFI

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

PIM

Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

NewSquare Capital's INFI Position: Q4 2020 in Review

NewSquare Capital sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q4 2020, closing a stake of 69,548 shares — an estimated $81K sold.

NewSquare Capital first reported a position in INFI in Q3 2018 and held it in 9 quarters. The position peaked at $131K in Q1 2019. 55 funds tracked by Wall St. Rank hold INFI as of Q4 2020.

NewSquare Capital reported no remaining Infinity Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
NewSquare Capital sold 69,548 Infinity Pharmaceuticals, Inc. shares in Q4 2020, an estimated $81K.
NewSquare Capital first reported a position in Infinity Pharmaceuticals, Inc. in Q3 2018 and held it in 9 quarters.
NewSquare Capital's Infinity Pharmaceuticals, Inc. position peaked at $131K in Q1 2019.
55 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q4 2020.

Based on NewSquare Capital's 13F filing for Q4 2020, filed 4 Feb 2021.